MedTech Color Member Exclusive: Harvard Catalyst On-Demand Course 

The Harvard Clinical and Translational Science Center is pleased to offer complimentary access to the on-demand course, Medical Device Development: Advancing from Product to Market (MDD), to members of MedTech Color. This self-paced course explores the evolving landscape of medical device development and includes:

• Real-world case studies highlighting critical challenges and considerations in device development
• Key factors in regulatory decision-making
• Techniques for technology valuation and identifying potential funding sources
• Best practices for designing a compelling, customizable pitch for key stakeholders 

Log in or become a member to get access.

Despite growing awareness and regulatory focus, achieving representative participation in clinical studies remains a persistent challenge. This webinar brings together leaders across clinical affairs, market access, and health economics to explore how organizations can better understand disease prevalence across diverse populations—and translate those insights into meaningful, actionable diversity strategies.

Moderated by MedTech Color Co-Founder and Board Treasurer Nada Hanafi, this session will highlight real-world approaches from Edwards Lifesciences and industry experts on developing and operationalizing diversity action plans—from interpreting FDA guidance to identifying data gaps, building cross-functional teams, and aligning stakeholders around measurable goals.

Whether you work in clinical development, regulatory affairs, market access, or health equity, this session will provide actionable frameworks to move from intention to impact.

Watch Webinar

This interactive session aims to raise awareness about cardiovascular diseases, promote health equity, and delve into significant health policy issues that could affect patients. We will emphasize cardiometabolic health challenges prevalent in communities of color, such as heart disease, diabetes, kidney disease, and obesity. We will also explore how recent federal policy changes may influence healthcare access and affordability.

Watch Webinar

Join us for a powerful and personal conversation. This webinar brings together a panel of experts who not only have firsthand experience with diabetes but who also are leading the charge in transforming diabetes technology. Our panelists are scientists, tech developers, regulatory experts and founders of innovative health tech companies. Don't miss this opportunity to hear how personal passion meets professional innovation that is shaping the future of diabetes technology.

Watch Webinar Access Diabetes Tech Resources

Navigating Stakeholder Impact: The FDA Landscape

This insightful session covers the significant changes at the FDA brought about by the current administration, and their effects on stakeholders. Join Steve Silverman and Kwame Ulmer for a conversation covering key areas such as the drastic reduction in FDA staff, effective communication strategies in light of staff limitations, post market considerations, and strategic responses for monitoring submissions and engaging with FDA staff. Gain valuable insights into navigating these changes to ensure premarket success, regulatory compliance, and product quality.

Log in to access the webinar recording.

Professional Journeys: Tips and Strategies from Women Leaders in MedTech | March 28, 2025

This webinar will focus on identifying various leadership roles in MedTech companies and the strategies and journeys of the women leaders who are impacting the MedTech industry.

The panel will cover an array of questions focused on their professional journeys in Medtech as women, advice and strategies for future senior leaders, and the unique perspectives they bring to the Medtech industry and to women in leadership. Log in to access the webinar recording.


Become a Member to View

Equity in Action: Redefining FDA Clinical Trials Through Inclusive Research

This informative session will delve into the critical importance of diversity in clinical trials and how inclusive research can drive meaningful change. This webinar promises to be an engaging and insightful discussion on the ways we can redefine FDA clinical trials through the lens of equity and inclusion. Your participation and perspective are highly valued, and we look forward to your contributions to this important conversation.

Watch Webinar